Re: C'mon Pfizer do something

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Payzone

Rank: Mail Room [?]

Points: 198 [?]

Votes: 6 Score: 4.8 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: C'mon Pfizer do something

in response to

C'mon Pfizer do something

GeorgeParros

posted on Jun 16, 2020 07:13PM

Great point GP. Last time I checked 5 of those compounds ZEN-3694 is highly synergistic with are Pfizer's. Not on that slide is Pfizer's TNBC drug Talazoparib we are currently trialing.

Enzalutamide (mCRPC) + Talazoparib (TNBC) + Palbociclib (ER+) .... what is Pfizer waiting for?

Enzalutamide

Palbociclib

Sunitinib

Crizotinib

Vidaza

6 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply